Skip to main content
. 2021 Feb 3;118(2):413–423. doi: 10.1093/cvr/cvab032

Figure 2.

Figure 2

Flow chart of cholesterol biosynthesis and key enzymatic steps that are targeted by key classes of lipid-lowering drugs, with the statins’ target sites broken down by canonical lipid-lowering and pleiotropic effects.